One Health and Development Initiative (OHDI)
Antimicrobials are medicines used to prevent and treat infections in humans, animals, and plants. They work by inhibiting or killing germs (pathogens) which are microorganisms and parasites that cause infections. These germs include bacteria, fungi, viruses, protozoans, helminths, and nematodes. Examples of antimicrobials include antibiotics (for bacterial infections), antifungals (for fungal infections), antivirals (for viral infections), and antiparasitics (for pathogenic parasites).
WHAT IS ANTIMICROBIAL RESISTANCE?
Antimicrobial Resistance (AMR) is a phenomenon in which germs (pathogenic organisms such as bacteria, viruses, fungi, and parasites) are no longer killed or inhibited by medications (antimicrobials) designed against them. This is caused by changes manifested by the germs in response to antimicrobials over time. These resistant germs are usually called “superbugs”. The most prominent type of AMR is antibiotic resistance which is the resistance of bacteria against antibiotics.
The main consequence of antimicrobial resistance (AMR) is that an infection caused by a resistant germ (pathogen) becomes harder or impossible to treat. This often leads to longer treatment periods, the use of stronger and more expensive last-line antimicrobials (which often have dire side effects), severe illness, and in extreme cases, failure of treatment that may lead to death. It also increases the risk of infection transmission – both between humans or from humans to animals and the environment (and vice versa)
The consequences of AMR have been increasing in occurrence and prevalence such that the World Health Organization (WHO) has declared AMR as one of the major global health threats in this century. In 2019, about 1.27 million deaths were caused by AMR and it is estimated that if proper actions are not taken, 10 million deaths will occur annually by 2050 (Antimicrobial Resistance Collaborators, 2022).
Although AMR may develop naturally, it is facilitated by actions such as the misuse and abuse of antimicrobials in both humans and animals.
This misuse and abuse expose pathogens (germs) to antimicrobials unnecessarily and this speeds up the rate at which the organisms will adapt to and become resistant to antimicrobials. Misuse and abuse are often caused by a lack of knowledge on the appropriate use of antimicrobials in humans and animals and the resulting dangers of antimicrobial resistance.
Antimicrobial resistance also develops when antimicrobials are used consistently in food-animal production to prevent or treat disease in food animals. This is usually done when people supplement animals’ feeds with antimicrobials in various doses. Oftentimes, the aim of this practice is to prevent disease in food animals. However, this constant use has contributed significantly to the development of resistant germs (pathogens) capable of causing infections in humans. When the pathogens in animals become resistant, they can be transferred to humans through direct contact, zoonotic infections, or the ingestion/consumption of infected animals and/or animal by-products.
DEVELOPMENT AND TRANSMISSION OF AMR IN THE ENVIRONMENT
This interaction emphasizes the suitability of the One Health approach in tackling AMR since One Health recognizes and addresses issues at the interconnections between human, animal, and environmental health. It is therefore important to adopt One Health in tackling AMR and strengthen global efforts to prevent and control its spread in humans, animals, and the environment.
Following the measures written above will help you combat AMR effectively, and keep you and your family safe from infectious diseases.
As One Health-focused organization, OHDI is celebrating this year’s World Antimicrobial Awareness Week with several informative activities including scheduled webinars and social media campaigns. To take this further, we have concreted plans to continue this conversation in various secondary schools, communities, and among professionals in the human, animal, and environmental health sectors. This will be one of the many projects we shall be undertaking to create more engagement and youth action around the AMR discourse. OHDI will continue to contribute to the global efforts against AMR through advocacy (both physical and virtual), research, and corresponding projects. We are happy to receive external collaborations and support to mitigate AMR and its negative impact across the One Health spectrum.
REFERENCES